ZA9811380B - - Google Patents

Info

Publication number
ZA9811380B
ZA9811380B ZA9811380A ZA9811380A ZA9811380B ZA 9811380 B ZA9811380 B ZA 9811380B ZA 9811380 A ZA9811380 A ZA 9811380A ZA 9811380 A ZA9811380 A ZA 9811380A ZA 9811380 B ZA9811380 B ZA 9811380B
Authority
ZA
South Africa
Prior art keywords
integer
formula
description
group
alkoxy
Prior art date
Application number
ZA9811380A
Other languages
English (en)
Inventor
Michel Langlois
Monique Mathe-Allainmat
Carole Jellimann
Jean Andrieux
Caroline Bennejean
Pierre Renard
Philippe Delagrange
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ZA9811380B publication Critical patent/ZA9811380B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/05—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/60—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/20—Acenaphthenes; Hydrogenated acenaphthenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/28—Phenalenes; Hydrogenated phenalenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/30—Ortho- or ortho- and peri-condensed systems containing three rings containing seven-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Furan Compounds (AREA)
ZA9811380A 1998-01-16 1998-12-11 ZA9811380B (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9800424A FR2773798B1 (fr) 1998-01-16 1998-01-16 Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ZA9811380B true ZA9811380B (cs) 1999-06-14

Family

ID=9521844

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9811380A ZA9811380B (cs) 1998-01-16 1998-12-11

Country Status (19)

Country Link
US (1) US6423870B1 (cs)
EP (1) EP1047664B1 (cs)
JP (1) JP2002509130A (cs)
CN (1) CN1247528C (cs)
AT (1) ATE267163T1 (cs)
AU (1) AU739488B2 (cs)
BR (1) BR9815081A (cs)
CA (1) CA2318381C (cs)
DE (1) DE69824046T2 (cs)
DK (1) DK1047664T3 (cs)
ES (1) ES2221999T3 (cs)
FR (1) FR2773798B1 (cs)
HU (1) HUP0100283A3 (cs)
NO (1) NO20003604L (cs)
NZ (1) NZ505323A (cs)
PL (1) PL195664B1 (cs)
PT (1) PT1047664E (cs)
WO (1) WO1999036392A1 (cs)
ZA (1) ZA9811380B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025355A (en) * 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
GB9726569D0 (en) * 1997-12-16 1998-02-11 Univ Southampton Neuroprotective agents
DE10133927A1 (de) * 2001-07-12 2003-01-23 Bayer Ag Benzodioxinothiophene, deren Herstellung und Verwendung
JP2005501841A (ja) * 2001-08-01 2005-01-20 バセル ポリオレフィン ジーエムビーエイチ 複素環式ペンタレン誘導体の製造方法
AU2007342806A1 (en) * 2006-12-28 2008-07-17 Takeda Pharmaceutical Company Limited Tricyclic compound and pharmaceutical use thereof
FR2934857B1 (fr) * 2008-08-05 2010-08-27 Servier Lab Nouveau procede de synthese de l'agomelatine
CN116209657A (zh) * 2020-08-06 2023-06-02 泰科根公司 用于精神障碍或增强的2-氨基茚满化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407919D0 (en) * 1994-04-21 1994-06-15 Glaxo Group Ltd Chemical compounds
DE69517433T2 (de) 1994-09-12 2001-02-08 Takeda Chemical Industries, Ltd. Benzozykloalkenverbindungen, deren herstellung und verwendung
FR2725985B1 (fr) * 1994-10-21 1996-11-15 Adir Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2732964B1 (fr) * 1995-04-14 1997-05-16 Adir Nouveaux amides tricycliques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2734815B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux composes arylalkyl (thio) carboxamides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
PL188093B1 (pl) * 1996-03-08 2004-12-31 Takeda Chemical Industries Ltd Związek trójpierścieniowy, sposób jego wytwarzania i zastosowanie, kompozycja farmaceutyczna oraz związki pośrednie

Also Published As

Publication number Publication date
CA2318381A1 (fr) 1999-07-22
ATE267163T1 (de) 2004-06-15
PL341837A1 (en) 2001-05-07
FR2773798B1 (fr) 2001-02-02
DE69824046D1 (de) 2004-06-24
HUP0100283A3 (en) 2002-05-28
BR9815081A (pt) 2000-10-17
ES2221999T3 (es) 2005-01-16
NZ505323A (en) 2002-10-25
HK1033455A1 (en) 2001-08-31
CN1285817A (zh) 2001-02-28
CN1247528C (zh) 2006-03-29
CA2318381C (fr) 2007-04-17
JP2002509130A (ja) 2002-03-26
EP1047664A1 (fr) 2000-11-02
DK1047664T3 (da) 2004-09-13
HUP0100283A2 (hu) 2002-04-29
AU1567699A (en) 1999-08-02
WO1999036392A1 (fr) 1999-07-22
EP1047664B1 (fr) 2004-05-19
US6423870B1 (en) 2002-07-23
NO20003604L (no) 2000-09-12
FR2773798A1 (fr) 1999-07-23
NO20003604D0 (no) 2000-07-13
PL195664B1 (pl) 2007-10-31
PT1047664E (pt) 2004-08-31
AU739488B2 (en) 2001-10-11
DE69824046T2 (de) 2005-06-30

Similar Documents

Publication Publication Date Title
AU5261598A (en) A1 adenosine receptor antagonists
MX9701253A (es) Compuesto de fenol y procedimiento para preparar el mismo.
IL105421A0 (en) Taxol derivatives
GB2346878A (en) Preparation of 3-substituted adenines
NZ335091A (en) Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivatives as vasodilators
DK0698012T3 (cs)
ZA976705B (en) Process for the synthesis of protected esters of (S)-3,4-dihydroxybutric acid.
MY108076A (en) Cationic compound and cleaning composition.
AU3744397A (en) Total synthesis of antitumor acylfulvenes
AU1162699A (en) Cosmetic composition comprising a compound such as indigoid
NO20001500D0 (no) Tricykliske triazolbenzazepinderivater, fremgangsmåte til fremstilling derav, samt antiallergiske midler
WO2002000638A8 (en) Substituted phthalides as anti-convulsive drugs
EP0947504A4 (cs)
ZA9811380B (cs)
ATE218060T1 (de) Zusammenstellungen die beta-amyloid protein bedingte zytotoxizität verhindern
WO1998049998A3 (de) Verwendung von glykosidischen siliconverbindungen zur herstellung von kosmetischen und/oder pharmazeutischen zubereitungen
IL131380A0 (en) The use of a compound for the manufacture of a pharmaceutical preparatin for the treatment or prevention of prostate cancer
ES2001102A6 (es) Un procedimiento para la preparacion de un derivado de indeno.
EP0987247A4 (en) ITACONATE DERIVATIVES AND THEIR USE AS COMPONENTS IN A POLYMER
WO2002040005A3 (en) Blockade of sodium channels by phenol derivatives
TW333554B (en) Benzidine derivative and electrophotosensitive material using the same
MX9701545A (es) Sales de na, k y li de compuestos de siloxi.